Home
About Us
Manager
Portfolio
News Center
Join Us
Contact Us
Company Profile
We focus on life science, health care, original innovation
Enran Ventures was established in 2015, focusing on venture capital companies in the fields of biomedicine and medical health. It currently manages eight equity investment funds with a management scale of more than 3 billion...
View Details
300000Million
Managed amount
65Companies
Invested companies
7Sticks
Number of funds
management team
View all team members>>
Mr. Chen Renhai
Mr. Chen Renhai
Mr. Liu Yihao
Mr. Liu Yihao
Mr. Shi Kaikai
Mr. Shi Kaikai
Ms. Zhang Yijia
Ms. Zhang Yijia
Ms. Yu Jing
Ms. Yu Jing
Mr. Deng Jintao
Mr. Deng Jintao
Mr. Cheng Yilang
Mr. Cheng Yilang
Portfolio
2023-02-28
Ennovation Ventures Portfolio丨Ennovation Ventures' many invested companies were listed in the "2022 China Biomedical Industry Chain Innovation List"
Recently, the "2022 China Biomedical Industry Chain Innovation Billboard" jointly initiated by China Biomedical Indu
2022-07-05
Ennovation Ventures Portfolio丨 Abiochem's listing application was formally accepted
Abiochem Biotechnology is a platform enterprise of synthetic biology, which focuses on synthetic biology techn
2022-04-27
Solemn Statement
Since its establishment in 2015, our company Ennovation Ventures has never authorized any unit or individual to a
2021-05-19
Ennovation Ventures Portfolio丨Committed to source innovation, Heqi Rui Medicine completed US$56 million in Series B financing to build a global innovation and R&D platform
May 6, 2021，Invested company Hope Medicine Inc (Heqirui Medicine)(hereinafter referred...
2021-05-11
Ennovation Ventures Portfolio丨Aimeifei completes 200 million yuan in Series A financing and is committed to the development of innovative drugs with global leading targets
On May 11, Nanjing Aimeifei Biomedical Technology Co , Ltd (Aimeifei for short) an...
2021-04-28
Ennovation Ventures Portfolio丨Yaojie Ankang Announces IND Application Submission, Double Happiness for Strategic Cooperation with LG Chem
Completion of the IND clinical trial application for TT-01025 submitted to China’s N...
2021-04-15
Ennovation Ventures Portfolio丨Clinical CRO service provider "Bestida" plans to be listed on A-shares
Baishida (Shanghai) Pharmaceutical Technology Co , Ltd (hereinafter referred to as B...
2021-04-12
Ennovation Ventures Portfolio丨Bendao Gene completed the A round of financing to create China's original delivery technology
Shanghai Bendao Gene Technology Co , Ltd (hereinafter referred to as Bendao Gene),...
2021-04-07
Ennovation Ventures Portfolio丨Double happiness is coming: Enze Kangtai was recognized as a "high-tech enterprise", and 5 products were selected as new technology and new products in Beijing
2021年1月7日根据《高新技术企业认定管理办法》（国科发火【2016】32号）和《高新技术企业认定管理工...
2021-04-06
Ennovation Ventures Portfolio丨Wolfman received a strategic investment of 172 million yuan from Blue Sail Medical to jointly promote the market of domestic OCT products
On April 6, 2021, Lanfan Medical Co , Ltd announced that it intends to jointly i...
View Details
Maybe you also want to know:
Join UsJoin Us Contact UsContact Us

Shanghai office address：Room 203, No. 1 Enran Commercial Plaza, Lane 5333, Zhoudeng Road, Pudong New Area, Shanghai　　Mail：info@ennovationvc.com
Nanjing Office Address：12th Floor, Block E, Olympic Sports Building, No. 130 Olympic Sports Street, Jianye District, Nanjing　　Mail：info@ennovationvc.com

Technical Support：Nanjing DingchengCOPYRIGHT © 2021 Ennovation Ventures ALL RIGHTS RESERVED. 苏ICP备17055409号-1